MG2512 Injection

MG2512 · Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MG2512 Injection, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MG2512 Injection in Participants With Advanced Solid Tumors [Phase 1]